Siglec-15 and Its Related Immune Phenotypes Can Predict the Efficacy of Breast Cancer with Neoadjuvant Chemotherapy

被引：0
|
作者：
Chen, Honglei [1 ]
Tian, Sufang [2 ]
机构：
[1] Wuhan Univ, Zhongnan Hosp, Ctr Pathol & Mol Diagnost, Wuhan, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Wuhan, Peoples R China
来源：
LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
125
引用
收藏
页码：S113 / S114
页数：2
相关论文
共 50 条
  • [1] Tumor immune microenvironment components and the other markers can predict the efficacy of neoadjuvant chemotherapy for breast cancer
    Weiqian Zhang
    Ke Xu
    Zhengfa Li
    Linwei Wang
    Honglei Chen
    Clinical and Translational Oncology, 2023, 25 : 1579 - 1593
  • [2] Tumor immune microenvironment components and the other markers can predict the efficacy of neoadjuvant chemotherapy for breast cancer
    Zhang, Weiqian
    Xu, Ke
    Li, Zhengfa
    Wang, Linwei
    Chen, Honglei
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (06): : 1579 - 1593
  • [3] Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
    Jun Wang
    Jingwei Sun
    Linda N. Liu
    Dallas B. Flies
    Xinxin Nie
    Maria Toki
    Jianping Zhang
    Chang Song
    Melissa Zarr
    Xu Zhou
    Xue Han
    Kristina A. Archer
    Thomas O’Neill
    Roy S. Herbst
    Agedi N. Boto
    Miguel F. Sanmamed
    Solomon Langermann
    David L. Rimm
    Lieping Chen
    Nature Medicine, 2019, 25 : 656 - 666
  • [4] Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
    Wang, Jun
    Sun, Jingwei
    Liu, Linda N.
    Flies, Dallas B.
    Nie, Xinxin
    Toki, Maria
    Zhang, Jianping
    Song, Chang
    Zarr, Melissa
    Zhou, Xu
    Han, Xue
    Archer, Kristina A.
    O'Neill, Thomas
    Herbst, Roy S.
    Boto, Agedi N.
    Sanmamed, Miguel F.
    Langermann, Solomon
    Rimm, David L.
    Chen, Lieping
    NATURE MEDICINE, 2019, 25 (04) : 656 - +
  • [5] Siglec-15/sialic acid axis as a central glyco- immune checkpoint in breast cancer bone metastasis
    Wang, Yixian
    Xu, Zhan
    Yu, Liqun
    Wang, Chenhang
    Ding, Haoxue
    Gao, Yang
    Sun, Han
    Xia, Meng
    Chen, Yuda
    Wu, Kuan- Lin
    Wu, Yi-Hsuan
    Xiao, Han
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (05)
  • [6] Immunopositivity for Siglec-15 in gastric cancer and its association with clinical and pathological parameters
    Leal Quirino, Michael Williams
    Pereira, Michelly Cristiny
    Deodato de Souza, Maria de Fatima
    Pitta, Ivan da Rocha
    da Silva Filho, Antonio Felix
    Albuquerque, Mario S. de Souza
    de Barros Albuquerque, Amanda Pinheiro
    Martins, Mario Rino
    da Rocha Pitta, Maira Galdino
    Barreto de Melo Rego, Moacyr Jesus
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2021, 65 (01): : 57 - 63
  • [7] Can MRI predict the response to neoadjuvant chemotherapy in breast cancer accurately?
    Fatayer, H.
    Kim, B.
    Daii, B.
    Sharma, N.
    Manuel, D.
    Shabaan, A.
    Perren, T.
    Velikova, G.
    Horgan, K.
    Lansdown, M.
    CANCER RESEARCH, 2012, 72
  • [8] MRI phenotypes predict response and recurrence in locallyadvanced breast cancer treated with neoadjuvant chemotherapy
    Yu, E
    Gibbs, J
    Au, A
    Chew, K
    Hylton, N
    Esserman, L
    Hwang, S
    Ewing, C
    Rugo, H
    Park, J
    Tripathy, D
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 (06) : 340 - 340
  • [9] Correlation of an immune-related 8-gene panel with the efficacy of neoadjuvant chemotherapy for breast cancer
    Liu, Chun-Yu
    Huang, Chi-Cheng
    Tsai, Yi-Fang
    Chao, Ta-Chung
    Lin, Yen-Shu
    Feng, Chin-Jung
    Lai, Jiun-I
    Chen, Ji-Lin
    Chen, Yen-Jen
    Chiu, Jen-Hwey
    Hsu, Chih-Yi
    Tseng, Ling-Ming
    CANCER RESEARCH, 2023, 83 (05)
  • [10] Neoadjuvant chemotherapy for breast cancer: an evaluation of its efficacy and research progress
    Chen, Yushi
    Qi, Yu
    Wang, Kuansong
    FRONTIERS IN ONCOLOGY, 2023, 13
12345